Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines.
D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D004175:Diptera / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism*; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000145:classification / Q000187:drug effects* / Q000378:metabolism; D012469:Salivary Glands / Q000378:metabolism
D000067956:Adenylyl Cyclase Inhibitors; D002395:Catecholamines; D010716:Phosphatidylinositols; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium